Drug-eluting stents at a crossroads: the good, the bad and the ugly

By Nammas Wail  

Future Cardiology, Vol. 8, Iss. 1, 2012-01 ,pp. : 1-3

Future Medicine

Access to resources Recommend Favorite

Reduction in Neutrophil Count During Hepatitis C Treatment: Drug Toxicity or Predictor of Good Response?

By Alvarez-Uria Gerardo   Day Jeremy   Nasir Anisa   Russell Susan   Vilar F.  

Digestive Diseases and Sciences, Vol. 55, Iss. 7, 2010-07 ,pp. : 2058-2062

Springer Publishing Company

Access to resources Recommend Favorite

Endocrinology. Bioequivalence of subcutaneous injections of recombinant human follicle stimulating hormone (Puregon ® ) by Pen-injector and syringe

By Voortman G.  

Human Reproduction, Vol. 14, Iss. 7, 1999-07 ,pp. : 1698-1702

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Ovulation induction with low dose alternate day recombinant follicle stimulating hormone (Puregon)

By Buckler H.M.  

Human Reproduction, Vol. 14, Iss. 12, 1999-12 ,pp. : 2969-2973

Oxford University Press

Access to resources Recommend Favorite

The use of a 100 IU starting dose of recombinant follicle stimulating hormone (Puregon) in in-vitro fertilization

By Devroey P  

Human Reproduction, Vol. 13, Iss. 3, 1998-03 ,pp. : 565-566

Oxford University Press

Access to resources Recommend Favorite